002349 精华制药
2024/09 - 九个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)6.59510.2249.1547.4005.609
总资产报酬率 ROA (%)5.1247.9566.8025.0583.641
投入资产回报率 ROIC (%)6.4729.9098.4796.4904.611

边际利润分析
销售毛利率 (%)49.86848.69346.73346.55748.311
营业利润率 (%)21.90421.88515.98713.2934.939
息税前利润/营业总收入 (%)18.59820.27814.95013.2156.280
净利润/营业总收入 (%)18.22818.28813.49510.3072.179

收益指标分析
经营活动净收益/利润总额(%)97.37199.04795.843102.590357.050
价值变动净收益/利润总额(%)2.4872.14511.77217.57316.265
营业外收支净额/利润总额(%)-1.655-0.352-0.508-0.9040.729

偿债能力分析
流动比率 (X)6.7725.4934.3812.6442.688
速动比率 (X)5.8134.6883.6022.1092.106
资产负债率 (%)10.06311.95413.74919.6540.212
带息债务/全部投入资本 (%)0.7441.5362.9179.85612.913
股东权益/带息债务 (%)13,251.9846,358.8253,295.692904.355667.826
股东权益/负债合计 (%)781.184642.053574.080355.719314.887
利息保障倍数 (X)-6.305-13.244-15.630327.0374.813

营运能力分析
应收账款周转天数 (天)70.41855.71649.51959.53771.712
存货周转天数 (天)150.654138.913135.503156.490177.771